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Abstract
Chlamydophila pneumoniae, an obligate intracellular eubacterium, changes its form from a vegetative reti-
culate body into an infectious elementary body during the late stage of its infection cycle. Comprehension
of the molecular events in the morphological change is important to understand the switching mechanism
between acute and chronic infection, which is deemed to relate to the pathogenesis of atherosclerosis.
Herein, we have attempted to screen genes expressed in the late stage with a genome-wide DNA microarray,
resulting in nomination of 17 genes as the late-stage genes. Fourteen of the 17 genes and six other genes
predicted as late-stage genes were conﬁrmed to be up-regulated in the late stage with a quantitative
reverse transcriptase–polymerase chain reaction. These 20 late-stage genes were classiﬁed into two
groups by clustering analysis: ‘drastically induced’ and ‘moderately induced’ genes. Out of eight drastically
induced genes, four contain s
28 promoter-like sequences and the other four contain an upstream common
sequence. It suggests that besides s
28, there are certain up-regulatory mechanisms at the late stage, which
may be involved in the chlamydial morphological change and thus pathogenesis.
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1. Introduction
Chlamydia and Chlamydophila species cause serious
health problems in both humans and animals. These
obligatory intracellular bacteria have apparently two
distinct forms: an extracellular, infectious, and unpro-
liferative elementary body (EB) and an intracellular,
proliferative, and uninfectious reticulate body (RB).
The beginning of infection is an attachment and
internalization of EBs into host cells, followed by
differentiation to RBs, deﬁned as an early stage. RBs
proliferate by binary ﬁssion in an inclusion at the
mid-stage. After the proliferation, RBs change back
to EBs at the late stage, and ﬁnally EBs are released
from host cells for the next infection cycle.
Accompanied with the morphological change during
the late stage, chlamydial transcription and DNA repli-
cation are inactivated, and the nucleoid is condensed
like heterochromatin of eukaryotic cells.
Chlamydophila pneumoniae is a causative agent of
pneumonia and bronchitis of human
1 and may
Edited by Katsumi Isono
* To whom correspondence should be addressed. Tel. þ81 836-22-
2227.Fax. þ81836-22-2415.E-mail:yazuma@yamaguchi-u.ac.jp
† Present address: Department of Veterinary Biosciences, The
Ohio State University, 1900 Coffey Rd., Columbus, OH
43210, USA
# The Author 2008. Kazusa DNA Research Institute.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the
open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal
and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently
reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use,
please contact journals.permissions@oxfordjournals.org
DNA RESEARCH 15, 83–91, (2008) doi:10.1093/dnares/dsm032contribute to the pathogenesis of atherosclerosis.
2 To
understand the pathogenesis, especially the mechan-
ism of persistent infection, it is important to elucidate
the molecular events in chlamydial development from
RBs to EBs during the late stage, which may be related
to the pathogenesis of atherosclerosis.
3 The morpho-
logical conversion at the late stage is unique in chla-
mydia and thus the contributing genes could be
targets for anti-chlamydosis therapy.
Chlamydiae have eukaryotic-type histone-like pro-
teins, Hc1 and Hc2, encoded by hctA and hctB genes,
respectively. Both proteins are produced speciﬁcally
during the late stage and known to be associated
with the concentrated nucleoid of EB.
4–10 Promoter
of hctB is recognized by s
28, one of the alternative
sigma factors in Chlamydia.
11 Thus, s
28 is thought to
play a role in late expression of genes in the develop-
mental cycle. Recently, it was reported that tlyC_1,
bioY, dnaK, fmu, and pgk genes are recognized by chla-
mydial s
28 in vitro.
12 The omcAB operon, ltuA, and ltuB
genes are also known as late genes.
13
So far there are two reports showing gene
expression proﬁle of Chlamydophila trachomatis
during its development using a DNA microarray.
14,15
Seventeen genes, including the known late genes
such as hctB, ltuB, omcA, and omcB, are commonly
annotated as late genes. However, the reports
include discrepancies in expression annotation for
many genes, especially for early-stage genes. It may
indicate a technical difﬁculty to analyze chlamydial
transcriptome in the early and mid phases of infection
with DNA microarray. In spite of these intensive
researches, molecular mechanism of chlamydial
development is still unclear. In the present study, we
developed C. pneumoniae DNA microarray covering
nearly all genes on the genome of C. pneumoniae
J138
16 and focused on analysis of the mid to late
stage of chlamydial gene expression.
2. Materials and methods
2.1. Cell and chlamydia culture
Infection, culture, and DNA preparation of C. pneu-
moniae J138 were performed as previously
described.
17 Brieﬂy, HEp-2 cells (ATCC CCL-23), a
human epithelioid larynx carcinoma-derived cell
line, were maintained using Iscove’s modiﬁed
Dulbecco’s medium (Gibco BRL, CA, USA) sup-
plemented with 10% heat-inactivated fetal calf
serum (FCS) (PAA Laboratories, Inc., USA) and 10 mg
gentamicin per milliliter. HEp-2 cells grown in 6-well
tissue culture plates for 24 h after passage were
infected with 1   10
6 inclusion forming unit (IFU)
of C. pneumoniae per well, resulting in multiplicity of
infection of 0.5. The inoculum was centrifuged at
700g for 1 h at 228C followed by incubation at
368C with 5% CO2 for one more hour. After the extra-
cellular bacteria were removed, infected cells were
further incubated in the same medium without 5%
of FCS and addition of 1.0 mg/mL cycloheximide
(Sigma, St. Louis, MO, USA). Growth curve of C. pneu-
moniae was determined as IFU by counting inclusion
bodies cultured on a 96-well plate as described pre-
viously.
18 Genomic DNA was extracted from puriﬁed
organisms with EZ1 DNA Tissue Kit (QIAGEN, Hilden,
Germany).
2.2. C. pneumoniae DNA microarray
We developed a DNA microarray composed of 884
DNA fragments covering 986 genes, except 83, from
the C. pneumoniae J138 genome. Of the 884 DNA
fragments, 497 cover one chlamydial gene or 23S
rDNA in each fragment, and the other 387 contain
plural genes since a part of the DNA fragments were
prepared using clones for random sequencing of C.
pneumoniae J138 genome.
16 Negative control DNA
fragments are prepared with adk gene from
Pseudomonas putida mt-2, and two human cDNA
of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and b-actin. DNA fragments were prepared
with polymerase chain reaction (PCR) and spotted
to two positions on a microarray glass.
2.3. Preparation of ﬂuorescent-labeled probes
and DNA microarray analysis
Total RNA was puriﬁed from cells both infected and
uninfected with C. pneumoniae J138 using RNeasy
(QIAGEN). Chlamydial RNA was enriched by removing
host mRNA and rRNA from the total RNA with mag-
netic beads of MicrobEnrich kit (Ambion, TX, USA).
19
Fluorescent-labeled cDNA probe was prepared using
RNA as the template with Atlas PowerScript
Fluorescent Labeling Kit (BD Biosciences Clontech,
CA, USA), Cy3, and Cy5 dye (Amersham).
Fluorescent-labeled genomic DNA was prepared
using 100 ng of puriﬁed chlamydial genomic DNA
as the template with random prime method using
BioPrime DNA Labeling System (Invitrogen, Carlsbad,
CA, USA), dNTPs (Amersham, NJ, USA) and ami-
noaryl-dUTP (Sigma), instead of biotin-dCTP and
Cy3 or Cy5 dye (Amersham). After PCR for ami-
noaryl-dUTP incoporation, the reaction was termi-
nated with ethanol precipitation. DNA resuspended
within 0.1 M sodium hydrogencarbonate was mixed
with the same volume of Cy3 or Cy5 dye solution dis-
solved in DMSO. After incubation at 378C for 1 h,
labeled DNA probes were puriﬁed with QIAquick
PCR puriﬁcation kit (QIAGEN). This method provides
ﬂuorescent-labeled genomic DNA probe sufﬁcient
for two or more times of hybridization. When the
84 C. pneumoniae Gene Expression [Vol. 15,genomic DNA probe was hybridized to the DNA
microarray, 15 of total 1768 chlamydial spots were
removed for further analysis due to under-detectable
intensity.
Separately ﬂuorescence-labeled cDNA probe and
the genomic DNA were mixed and hybridized compe-
titively to a microarray glass at 608C for 16 h, as pre-
viously described.
20 After washing, the glass was
scanned with FLA-8000 (Fujiﬁlm, Tokyo). Threshold
of each experiment was determined as an average
plus a value of standard deviation from negative
spot intensities. Only spots with higher ﬂuorescent
intensity than the threshold were further analyzed.
Gene expression value at each spot was calculated as
a ratio of intensity of cDNA ﬂuorescence against that
of genomic DNA.
To normalize and compare data from each RNA
preparation, ompA gene was adopted as a continu-
ously expressing standard due to the following
reasons. First, global normalization using neither
mean nor median is not appropriate for our data,
because the detection rate varies remarkably from
the time of infection (Fig. 1A). Secondly, microarray
spots for chlamydial 23S rRNA showed non-speciﬁc
signals derived from host RNA, and the amount of
chlamydial rRNA was affected by MicrobEnrich treat-
ment which is unavoidable for a reliable chlamydial
DNA microarray analysis (data not shown). Thirdly,
gene expression pattern of the ompA was similar to
one of the chlamydial ribosomal RNA based on the
reverse transcriptase–PCR (RT–PCR) analysis when
no MicrobEnrich treatment was carried out
(Supplementary Fig. S2C). At last, the ompA gene
was detected with the DNA microarray at all points
analyzed, and the amount of the ompA gene transcript
was not affected by treatment with MicrobEnrich
(data not shown).
2.4. Quantitative RT–PCR
Quantitative RT–PCR was carried out with total
RNA extracted from infected cells using QuantiTect
SYBR Green RT–PCR Kit (QIAGEN) with LightCycler
(Roche). In the RT–PCR, total RNA was directly sub-
mitted to RT reaction without the MicrobEnrich treat-
ment. Therefore, signals of chlamydial rRNA were
used as references, and with this rRNA reference, it
was conﬁrmed that the ompA gene is continuously
expressed. RNA puriﬁed from the cells at 24, 36, 48,
60, and 72 h after infection was diluted appropriately
for assay, and was mixed with primers and reagents.
Primer sequences used in this work are summarized
in Supplementary Table S1. The reaction was per-
formed according to the manuals from suppliers.
Expression amount of each gene was normalized
with that of chlamydial 16S rRNA.
2.5. Clustering and statistical analysis
Data were normalized by median of each gene
before clustering. Clustering analysis of the data was
performed with ‘Cluster’,
21 and the results were
viewed with ‘TreeView’. Statistical comparisons were
made using Wilcoxon’s t-test and Mann–Whitney’s
U-test for analysis of the DNA microarray data and
Chi square test for gene deviation analysis. P-value of
,0.05 were considered signiﬁcant.
3. Results
3.1. Chlamydial DNA microarray analysis
To distinguish the mid and late stages in the intra-
cellular development of C. pneumoniae J138, the
timing of progeny production was examined prior to
analyzing gene expression during differentiation
from EBs to RBs. The number of re-infectious proge-
nies starts to increase between 36 and 48 hours
post-infection (hpi) of C. pneumoniae J138 to HEp-2
cells (Fig. 1). Thus, in this work, the late stages in
developmental cycle were deﬁned after 48 hpi.
When RNAs are prepared from chlamydia infection
samples, amount of host RNA contamination is gener-
ally critical for data sensitivity and reliability. To
reduce host cell RNA from total RNA, MicrobEnrich
Kit was adopted to enrich chlamydial RNA before
labeling, and the J138 genomic DNA was used as a
counter control of the RNA to be tested. As with the
RNA at 24 hpi, approximately 30% of chlamydial
spots (total of 1768 spots by duplication of 884
DNA fragments covering 986 genes) exhibited
higher ﬂuorescence intensity than a threshold. At
60 hpi, 1508 spots were detected and the ratio of
Figure 1. Gene expression analysis with DNA microarray.
Reproduction of infectious progenies of C. pneumoniae J138
(shown on left as ‘Infectivity’) and detection rate of spots (on
right) by Cy3-labeled cDNA hybridization on DNA microarray.
1608 valid spots were chosen based on Cy5-labeled genome
hybridization. Percentage of the spots with intensity over
threshold, when the cDNA probe was hybridized, was
represented. When dyes were ﬂipped, similar results were
obtained.
No. 2] K. Miura et al. 85positive spots increased up to 93.8%, whereas 1608
spots were detected with genomic DNA as reference
spots for cDNA (Fig. 1). The low detection ratio with
RNAs from 24 hpi may be due to low concentration
of chlamydial RNA in the total RNA, which still con-
tains certain amount of the host RNA even after
enrichment of chlamydial RNA using MicrobEnrich
Kit. At earlier time point than 24 hpi ﬂuorescent
signals on the array were critically weak and the
data were much less reliable than that after 24 hpi.
Herein, we have focused on gene expression
between mid and late stages (24–72 hpi).
3.2. Genome-wide gene expression analyses with
chlamydial DNA microarray
Using chlamydial RNA-enriched RNA samples at
24–72 hpi, stage-speciﬁc gene expression was ana-
lyzed with external and internal controls, which
were C. pneumoniae J138 genomic DNA and ompA
gene product, respectively. The spots without
genomic DNA signals were eliminated from the data
analyses as detection errors. Relatively strong and con-
stitutive ompA gene expression was adopted as an
internal control to normalize individual experiments
of DNA microarray analysis (for detail, see Section
2). Out of 1768 spots duplicated by 884 DNA frag-
ments carrying a total of 986 genes of C. pneumoniae
J138, the amount of detected spots were varied at
24–72 hpi, such as only 30% of whole spots were
detected at 24 hpi while the maximum detection
rate, 85% (1508 positive spots), was observed using
60 hpi RNA sample (Fig. 1). In order to screen late-
stage-speciﬁc genes, duplicated spots for each DNA
fragment were treated as two individual spots, and a
clustering analysis was performed using the data of
approximately 400 out of 1768 spots, intensities of
which were higher than threshold at any time point
(Fig. 2A).
The result from the clustering analysis indicates that
expression of most genes tends to diminish from mid
to late stage of infection. Approximately a half of the
Figure 2. Clustering analysis of microarray data. (A) The data were normalized with ompA expression as described under Section 2. A
hierarchical cluster was obtained by analysis of 440 data. (B) A magniﬁed view of a cluster in a rectangle with a broken line in the
(A). Spot names (S01–S23) and gene IDs (CPjXXXX) are represented on the right side.
86 C. pneumoniae Gene Expression [Vol. 15,genes is drastically down-regulated, and the other half
of the genes is constitutive or gradually decreased. In
contrast, 22 spots, including duplicated spots for
same DNA fragments, exhibited an upward trend
with respect to time as a cluster collected on one
side of the clustering result (box in Fig. 2A and B). A
total of 17 genes in the 22 spots were assigned as
candidates of the late genes and compared with
results reported previously, including a proteomic
analysis in Table 1.
3.3. Identiﬁcation of late genes by quantitative
RT–PCR
Expression proﬁles of the 17 genes classiﬁed as late
genes based on the DNA microarray were analyzed
with quantitative RT–PCR using RNA harvested at
24, 36, 48, 60, and 72 hpi (Supplementary Fig. S2).
Fourteen (82%) of the 17 genes were conﬁrmed to
be induced at the late stage (Table 1). However, the
other three genes, CPj0148, CPj0934, and CPj0935,
were constitutive in the RT–PCR analysis. The DNA
Table 1. Summary of DNA microarray and RT–PCR analyses
Gene ID Name Deﬁnition Microarray RT–
PCR
Mukhopadhyay
et al.
a
CT
b Nicholson
et al.
a
Belland
et al.
a
CPj0331 – CT082 hypothetical protein Late I ND CT082 Late ND
CPj0332 – CHLTR T2 protein Late I ND –
CPj0333 ltuB LtuB protein Late I ND CT080 Late Late
CPj0558 omcA 9 kDa cysteine-rich lipoprotein Late I ND CT444 Late Late
CPj0416 himD Integration host factor alpha Late II ND CT267 Midlate-I ND
CPj0453 pmp14 Polymorphic outer membrane
protein H family
Late II ND CT872 Midlate-I Late
CPj0708 – CT668 hypothetical protein Late II ND CT668 Midlate-I ND
CPj0709 – CT667 hypothetical protein Late II ND CT667 Midlate-I ND
CPj0710 – CT666 hypothetical protein Late II Up CT666 Midlate-I ND
CPj0728 – CHLPN 76 kDa homolog_1
(CT622)
Late II ND CT622 Late ND
CPj0854 ompB Outer membrane protein B Late II ND CT713 Midlate-II ND
CPj0933 – Disulﬁde bond isomerase Late II ND CT783 Midlate-II Late
CPj0970 yccA2 Transport permease Late II ND CT819 Midlate-I ND
CPj0971 ftsY Cell division protein ftsY Late II ND CT820 Constitutive ND
CPj0148 – S/T protein kinase Late Const. ND CT145 Constitutive ND
CPj0934 rnpA Ribonuclease P protein
component
Late Const. ND CT784 Constitutive ND
CPj0935 rl34 L34 ribosomal protein Late Const. ND CT785 Constitutive ND
CPj0577 – SWIB (YM74) complex protein NL Const. ND CT460 Constitutive ND
CPj0695 ompA Major outer membrane protein NL Const. Up CT681 Midlate-II ND
CPj0769 topA DNA topoisomerase I-fused to
SWI domain
NL Const. ND CT643 Late ND
CPj0878 set SET domain protein NL Late
c ND CT737 Constitutive ND
CPj0244 adk Adenylate kinase NC I Up CT128 Constitutive ND
CPj0384 hctB Histone-like protein 2 NC I ND CT046 Late Late
CPj0678 – Hypothetical protein NC I ND –
CPj0886 hctA Histone-like developmental
protein
NC I ND CT743 Constitutive Late
CPj0466 pmp15 Polymorphic outer membrane
protein E family
NC II ND CT869 Late ND
CPj0559 – CT444.1 hypothetical protein NC II ND CT444.1 ND ND
CPj0238 zwf Glucose-6-P dehyrogenase NC Const. ND CT185 Constitutive ND
CPj0679 pgk Phosphoglycerate kinase NC Const. ND CT693 Late ND
Late, late-stage gene; NL, not-late-stage genes (mid or constitutive genes); NC, not clustered in Fig. 2A; I, class I; II, class II;
Const., constitutive in Fig. 3; ND, not determined.
aThe classiﬁcations follow the cited reference.
bOrtholog of C. trashomatis represented as gene number. ‘ 2 ’, no ortholog.
cMurata et al (2006).
No. 2] K. Miura et al. 87fragment containing CPj0934 and CPj0935 for the
DNA microarray also carries CPj0933, which is con-
sistently categorized into the late gene (S14–S17 in
Fig. 2B).
Expressions of other 11 genes, which were not cate-
gorized into the late genes in the microarray analysis,
were also examined with quantitative RT–PCR.
CPj0466 (pmp15, polymorphic outer membrane
protein E family) and CPj0679 (pgk, phosphoglycerate
kinase) were reported as late-stage genes in C. tracho-
matis gene expression and C. pneumoniae proteome
analysis.
14,22 CPj0244 (adk gene) was tested because
the gene product adenylate kinase (AK) was reported
to increase in protein amount in the RB–EB transition
stage of C. pneumoniae.
22 Four genes, CPj0878 (set,S E T
domain protein), CPj0769 (topA, DNA topoisomerase
I-fused to SWI domain), CPj0886 (hctA, histone-like
developmental protein), and CPj0384 (hctB, histone-
like protein 2), which are partially similar to eukaryotic
chromatin structure regulation or polycomb complex
proteins, were also reported as late-stage
genes
10,15,22 Here, we tested one more gene,
CPj0577 (SWIB complex protein), which is eukaryotic
chromatin structure regulation or polycomb complex
proteins. CPj0678 (hypothetical protein) and
CPj0559 (CT444.1 hypothetical protein) were tested
to distinguish their expression from adjacent genes
CPj0679 and CPj0558, respectively. CPj0695 (ompA,
major outer membrane protein) and CPj0238 (zwf,
glucose-6-P dehyrogenase) were tested as controls for
constitutive expression.
A total of 28 genes were examined with quantitative
RT–PCR using RNA harvested at 24–72 hpi
(Supplementary Fig. S2). These 28 genes were
divided into three clusters based on the results of the
clustering analysis (Fig. 3, Table 1, Supplementary Fig.
S2A). Eight genes were categorized as class I genes
thatwereinducedsharply(morethanﬁvetimesinduc-
tionratio) atthe latestage, 12genes were classIIgenes
inducedmoderately(fromtwotoﬁvetimes)atthelate
stage, and the other eight were constitutive genes. Out
of the 20 late genes, hctA, hctB, adk, and CPj0710 are
known as late genes in C. pneumoniae,
10,22 and other
16 genes are identiﬁed as novel late genes.
3.4. Conserved sequences in the late genes
Chlamydial gene expression at the late stage has
been analyzed using C. trachomatis, and it has been
proposed that s
28 RNA polymerase is involved in the
late gene expression.
12,23,24 We compared upstream
sequences of the C. pneumoniae late genes identiﬁed
here. Four out of the eight class I genes, hctB, ltuB,
CPj0332, and adk, contain similar sequences to the
235 consensus of Escherichia coli s
28 promoter at
approximately 60 nucleotides upstream of each
putative translation initiation site of gene
25
(Fig. 4A). It has been reported that AT-rich sequence
upstream of promoter is one of the s
28 preferences
by Shen et al.
24 In fact, these genes have an AT-rich
sequence upstream of 235 consensus. These ﬁndings
suggest that s
28 RNA polymerase transcribes these
genes. However, the CGA motif for 210 s
28 promoter
was not found except in the hctB gene, suggesting that
the consensus sequence of chlamydial s
28 promoter
is different from E. coli.
The other four genes in class I, CPj0331, CPj0678,
omcA, and hctA, contain no sequences similar to the
typical s
28 promoter, but a conserved AT-rich
sequence, AnAAnAnTTnTATTTTCTnTT, approximately
100 nucleotides upstream from each predicted gene
start site (Fig. 4B). The conserved AT-rich sequence
was not found in other class I, class II, and constitutive
genes determined with RT–PCR. Moreover, a part of
the AT-rich sequence, such as TAnnTTC, was also
found upstream of the orthologous genes of C. tracho-
matis. It may suggest that the AT-rich sequence (or a
part of it) is conserved in the distinctive chlamydial
genera and may be involved in late gene expression
of the orthologues.
Unlike hctB gene, adk and ltuB genes of C. trachoma-
tis have no s
28 consensus sequence, even though ltuB
gene of C. trachomatis is also a late gene. There is no
orthologous gene of CPj0332 in C. trachomatis
genomes. These differences between C. pneumoniae
and C. trachomatis suggest two possibilities: one is
that s
28 of these bacteria is capable of recognizing
the distinct sequence and/or regulates the distinct
Figure 3. Clustering analysis of RT–PCR data. The relative expression
data normalized with chlamydial 16S rRNA were subjected to
clustering analysis to classify genes. Transcript of hctA and hctB
genes was under detection limit at 24 hpi with RT–PCR.
According to the dendrogram, genes were classiﬁed in three
groups.
88 C. pneumoniae Gene Expression [Vol. 15,set of genes, and the other is that there is a distinct
regulation mechanism for late expression in each
species.
The late genes, CPj0331, CPj0332, and ltuB
(CPj0333), are tandem located on a same strand, sep-
arated by 220, 141, and 95 bp intergenic spaces
upstream of these genes, respectively. Our results
revealed that upstream non-coding regions of ltuB
and CPj0332 contain s
28 promoter-like sequences,
suggesting that these two promoters are individually
recognized by s
28 RNA polymerase.
4. Discussion
Here we describe a transcriptome proﬁle of C. pneu-
moniae in the late stage of the infection using DNA
microarray and quantitative RT–PCR. Based on the
DNA microarray screening, 17 C. pneumoniae genes
were nominated as up-regulated genes in the late
stage of infection, whereas approximately half of the
genes analyzed are constitutively expressed through
infection and the other half were down-regulated in
the late stage. The 17 genes shown as late genes by
the DNA microarray and 11 genes predicted as late
genes based on its sequence and functional similarities
to genes expressed in late stage in other chlamydial
species were analyzed with quantitative RT–PCR. As a
result, a total of 20 genes (14 out of the 17 genes
and six of the 11 genes) were conﬁrmed as late
genes. Previously, we demonstrated that hctA, hctB,
and set genes of C. pneumoniae are expressed at the
late stage of infection.
10 AK encoded by adk gene
and product of Cpn0710, an orthologue of CPj0710,
have been identiﬁed to be increased in the RB–EB tran-
sition stage of C. pneumoniae.
22 Thus, except for these
genes, we identiﬁed 16 novel late genes in this study.
Expression of ompB, adk, and Cpn0710 genes are
increased by interferon-g (IFN-g)t r e a t m e n t .
26,27
These ﬁndings indicate that there are some mechan-
isms shared by molecular systems leading to the per-
sistent infection (RBs to atypical RBs) induced by IFN-
g and to the late stage (RBs to EBs). The 20 late
genes were divided into two classes by the clustering
analysis: eight sharply induced genes (class I) and 12
moderately up-regulated genes (class II). The class I
Figure 4. Consensus sequence upstream of class I late genes. (A) Multiple alignment of upstream sequences of hctB, ltuB, CPj0332, and adk
genes. They have a consensus sequence partially similar to s
28 promoter consensus sequence. (B). Multiple alignment of upstream
sequences of CPj0331, CPj0678, omcA, and hctA genes of C. pneumoniae and the ortholog genes in C. trachomatis (CT). CT082 is the
ortholgog of CPj0331. Number represents nucleotides from the putative translation initiation site. Consensus sequences are
determined as three or more of four nucleotides are identical in C. pneumoniae genes, or two or more are identical in C. trachomatis.
Asterisks represent conserved nucleotides in all genes in each species. Highly conserved regions in C. pneumoniae genes are boxed
with dashed lines. Sequence logos are generated with WebLogo (http://weblogo.berkeley.edu/) using aligned sequences of C.
pneumoniae genes.
No. 2] K. Miura et al. 89genes, hctA, hctB, omcA, ltuB, adk, CPj0678, CPj0331,
and CPj0332, begin to be induced synchronously
when the conversion from RBs to EBs starts at around
48 hpi. As hctA and hctB genes are believed to contrib-
ute to the transition of RBs to EBs, somehow other six
class I genes may play their roles or explain the cellular
status in the late stage.
Four genes (hctB, ltuB, adk, and CPj0332) out of
eight class I genes contain the upstream sequences
which may be recognized by s
28 RNA polymerase,
supporting the hypothesis that s
28 RNA polymerase
is responsible for late gene expression.
12,23,24
However, the late gene, ltuB,o fC. trachomatis does
not have the s
28 consensus sequence, suggesting a
distinct mechanism, which allows the late expression
of the gene without s
28 in C. trachomatis.
In contrast, the other four genes of class I (CPj0331,
omcA, CPj0678, and hctA)h a v en os
28 promoter-like
sequence, suggesting the presence of other mechan-
ism(s) of late expression. Instead, we found a
common AT-rich sequence around 2100 nucleotides
upstream of them (Fig. 4B), suggesting that it plays a
role in late expression. In addition, the sequence was
also conserved partially upstream of the orthologous
genes of C. trachomatis. This sequence is not similar
to the known promoter sequences and far from
each gene. In fact, the core TAnnTTC of C. trachomatis
hctA gene is located at 245 to 251 from the tran-
scription initiation site.
13 Therefore, it might be a
binding site of regulatory protein(s) rather than a pro-
moter sequence.
AK catalyzes a reversible high-energy phosphoryl
transfer reaction between adenosine triphosphate
(ATP) and AMP to generate ADP and is considered
to contribute to the homeostasis of cellular
adenine nucleotide composition in the cell.
17 There
might be two possible reasons why the adk gene is
up-regulated at the late stage of infection: one is
that AK is necessary to increase ATP concentration
or to decrease ADP concentration, and the other is
that it is necessary to decrease AMP concentration.
In the ﬁrst case, AK produces ATP and AMP from
ADP. Because a Km (Michaelis constant) value for
AMP of the AK is remarkably higher than other
AKs,
17 accumulation of AMP seems not to affect
the reaction. In the second case, ADP is produced
to consume AMP through the opposite reaction.
Because ADP is a substrate of chlamydial ADP/ATP
translocase, it could promote to get ATP from the
host cell. We cannot conclude here which is more
likely. However, in many organisms intracellular
adenine nucleotide balance is strictly regulated, and
change of the balance induces various responses in
the cell, including not only metabolism regulation,
but also cell differentiation. In Bacillus subtilis increase
of ADP (or low ATP/ADP ratio) is hypothesized to be a
cell differentiation signal for sporulation.
28 Therefore,
also in C. pneumoniae the change of adenine nucleo-
tide balance could induce not only adk gene, but
also other late genes to differentiate RB into EB.
In the class II genes, himD gene encoding a subunit
of histone-like protein integration host factor and
pmp15 gene encoding outer membrane protein are
up-regulated transiently at 60 hpi. This temporary
enhancement of expression was consistent with the
results of binding assay in vitro using an extract from
C. trachomatis reported by Zhong et al.
29 Expression
of set gene encoding SET domain protein has been
previously reported to be expressed during late stage
accompanied with one of hctA and hctB genes,
10
suggesting that it plays an important role in chlamy-
dial development by the chlamydial histone-like
protein modiﬁcation.
Recently, OmcB protein of C. trachomatis, one of the
products of late omcAB operon, has been revealed to
be a surface-exposed adhesion to infect the host
cell.
30 Likewise, other membrane proteins encoded
by late genes identiﬁed here, omcA, pmp14, pmp15,
and ompB, might function to attach to the host cell.
In this study, we have identiﬁed 16 novel late genes
of C. pneumoniae and predicted cis-acting sequences
common in upstream regions of the late genes. The
genome sequence of Chlamydia contained a small
number of regulatory systems, a single pair of bac-
terial two-component system, and only several tran-
scription factors. However, our results suggest that
regulation of gene expression in C. pneumoniae
might be more complicated than expected. Further
investigation using a DNA microarray may help to
understand chlamydial physiology and pathology.
Supplementary Data: Supplementary data are
available online at www.dnaresearch.oxfordjournals.
org.
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